Mahamaya Lifesciences Ltd
BSE: 544611
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q2 FY25 |
|---|---|---|
| INCOME | ||
| Revenue | 163.06+0.0% | 163.06 |
| Other Income | 1.27-0.3% | 1.27 |
| Total Income | 164.33+0.0% | 164.33 |
| EXPENSES | ||
| Expenditure | 152.76-0.0% | 152.76 |
| Tax | 3.04+0.0% | 3.04 |
| PROFIT | ||
| PBT | 11.57-0.0% | 11.57 |
| Net Profit | 8.53-0.0% | 8.53 |
| KEY METRICS | ||
| OPM % | 3.28%-3.82pp | 7.10% |
| NPM % | 5.19%-0.04pp | 5.23% |
| EPS | 4.80 | — |
Corporate Events
Board MeetingMAHALIFE
202625May
Board Meeting
To consider and approve the Audited Standalone and Consolida…
BSE Filing ↗